Skip to content

The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery.

The Effect of Intranasal Insulin Administration on Cognitive Function After Cardiac Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03324867
Enrollment
316
Registered
2017-10-30
Start date
2022-04-30
Completion date
2023-04-30
Last updated
2021-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cognitive Decline, Heart Diseases, Delirium

Brief summary

Decline in cognitive function after surgery occurs most commonly in older patients and patients undergoing major surgeries, such as heart surgery. Postoperative Cognitive Dysfunction (POCD) may last a prolonged period of time while Postoperative Delirium (POD) is a more acute disturbance in attention, awareness and cognition. The cause of POCD and POD are not fully understood, however some of the pathophysiology of POCD is similar to that of Alzheimer's disease (AD). Insulin given intravenously during heart surgery has been shown to preserve short and long-term memory function after the operation. Clinical trials further demonstrated that insulin given via the nose (intranasal) improves memory performance of patients with AD or cognitive impairment suggests that intranasal insulin also could be a therapeutic option for POCD and POD. This study is designed to examine the effect intranasal insulin on POCD and POD. The goal is to investigate whether administration of intranasal insulin during and after heart surgery improves cognitive function postoperatively.

Interventions

40 IU of Humulin-R to be administered via nose using metered nasal dispenser prior to surgery, and up to 7 days after surgery.

Placebo: Normal Saline to be administered via nose using metered nasal dispenser prior to surgery, and up to 7 days after surgery

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• elective open heart surgery requiring cardiopulmonary bypass

Exclusion criteria

* inability to provide informed consent * allergy to insulin * pregnancy * mother tongue other than English or French * visual or hearing impairment interfering with the ability to complete cognitive tests.

Design outcomes

Primary

MeasureTime frameDescription
Confusion Assessment method for the ICUan average of 5 daysPost Operative Delirium
Rey Auditory Verbal Leaningup to 12 monthEpisodic Memory Lowest score: 0 Highest Score: 15
Rey-Osterrieth Complex Figure Test:up to 12 monthEpisodic Memory Lowest score: 0 Highest Score: 8

Secondary

MeasureTime frameDescription
Symbol Digit Modalities Testup to 12 monthInformation Processing Speed
Stropp Testup to 12 monthExecutive Function
Clock Drawing Testup to 12 monthVisuospatial Function Lowest score: 1 Highest score: 10
Boston Naming Testup to 12 monthLanguage Lowest score: 0 Highest score: 60
Trail Making Testup to 12 monthExecutive Function
Tower of London testup to 12 monthExecutive Function

Contacts

Primary ContactThomas Schricker, M.D., PhD.
thomas.schricker@mcgill.ca5149341934
Backup ContactHiroaki Sato, M.D., PhD.
hiroaki.sato2@mcgill.ca5149341934

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026